Article Text

Download PDFPDF
An innovative joint approach to HIV and lymphoma care
  1. Rageshri Dhairyawan1,
  2. Sarah Longwill1,
  3. Chloe Orkin1,
  4. Silvia Montoto2
  1. 1Department of Infection and Immunity, Barts and the London NHS Trust, London, UK
  2. 2Centre for Haemato-oncology, Barts Cancer Institute, London, UK
  1. Correspondence to Dr Rageshri Dhairyawan, Ambrose King Centre, Royal London Hospital, Whitechapel Road, London E1 1BB, UK; rdhairyawan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The prognosis of patients with HIV and lymphoma has improved in the highly active anti-retroviral therapy era. The British HIV Association's clinical standards1 state that the care of patients with diagnosed or suspected lymphoma should be transferred to a HIV centre provider of specialised HIV …

View Full Text


  • Competing interests None.

  • Patient consent Consent was not obtained as patients cannot be identified from the piece.

  • Ethics approval Ethics approval was not deemed necessary as this was a service evaluation.

  • Provenance and peer review Not commissioned; internally peer reviewed.